Filing Flows › Cronos Group (CRON) › Q2 2026 › vs Q1 2026
Cronos Group (CRON) Q2 2026 vs Q1 2026 (quarter over quarter)
Cronos Group's revenue rose $11.6M (+20%) from $59.0M in Q1 2026 to $70.6M in Q2 2026. The biggest changes: Cannabis flower +$5.5M (+16%); Other revenues +$3.8M (+28%); Cannabis extracts +$2.3M (+20%). Gross margin 40.3% against 32.5% (+7.8 pts).
Cronos Group, Q2 2026: revenue $70.6M (+60% year over year), operating margin 10.5%, net earnings $32.1M, operating cash flow $24.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 40.3% | 32.5% | +7.8 pts |
| Operating margin | 10.5% | -3.1% | +13.6 pts |
| Net margin | 45.4% | 23.3% | +22.1 pts |
| Free cash flow margin | 31.5% | 15.3% | +16.2 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Cannabis flower | $39.2M | $33.7M | $5.5M | +16% |
| Cannabis extracts | $13.8M | $11.5M | $2.3M | +20% |
| Other | $19K | $19K | $0 | 0% |
| Other revenues | $17.6M | $13.8M | $3.8M | +28% |
| Revenue | $70.6M | $59.0M | $11.6M | +20% |
| Gross profit | $28.5M | $19.2M | $9.3M | +49% |
| Cost of revenue | $42.1M | $39.8M | $2.3M | +6% |
| Other income, net | $28.3M | $20.0M | $8.3M | +42% |
| Operating profit | $7.4M | −$1.8M | $9.2M | — |
| Operating expenses | $21.0M | $21.0M | $61K | +0.3% |
| Pre-tax earnings | $35.7M | $18.1M | $17.6M | +97% |
| Research & development | $1.2M | $1.4M | −$198K | -14% |
| Sales & marketing | $6.8M | $5.6M | $1.2M | +21% |
| General & admin | $10.8M | $11.7M | −$933K | -8% |
| Other operating costs | $2.2M | $2.2M | $22K | +1% |
| Net earnings | $32.1M | $13.8M | $18.3M | +133% |
| Minority interests | $3.6M | $2.0M | $1.6M | +83% |
| Income tax | $51K | $2.4M | −$2.4M | -98% |
| Depreciation & amortization | $3.4M | $3.7M | −$353K | -9% |
| Share-based compensation | $1.6M | $1.3M | $244K | +19% |
| Working capital & other | $13.0M | $7.9M | $5.1M | +65% |
| Operating cash flow | $24.0M | $10.9M | $13.1M | +120% |
| Free cash flow (OCF − capex) | $22.3M | $9.0M | $13.2M | +147% |
| Capital expenditures | $1.7M | $1.9M | −$136K | -7% |
Questions
How much did Cronos Group's revenue grow quarter over quarter in Q2 2026?
Cronos Group's revenue rose $11.6M (+20%) from $59.0M in Q1 2026 to $70.6M in Q2 2026.
What drove Cronos Group's revenue change in Q2 2026?
Cannabis flower +$5.5M (+16%); Other revenues +$3.8M (+28%); Cannabis extracts +$2.3M (+20%).